Compare Ginkgo Bioworks Holdings Inc (DNA) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Medtronic PLC — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Medtronic PLC trades at $90.48 (market cap $116.07B). The key difference: Medtronic PLC is far larger — about 229.5× Ginkgo Bioworks Holdings Inc's market cap, and Medtronic PLC pays a 3.18% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | MDT | |
|---|---|---|
Market Cap | $505.73M | $116.07B |
Sector | Health | Health |
52-Week High | $16.14 | $105.35 |
52-Week Low | $5.48 | $73.75 |
Enterprise Value | $607.68M | $134.82B |
Dividend Yield | — | 3.18% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
